Published in Vopr Virusol on October 02, 1991
A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses. J Virol (2005) 1.42
Advanced vaccine candidates for Lassa fever. Viruses (2012) 0.90
Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses. Virus Genes (2006) 0.88
The search for animal models for Lassa fever vaccine development. Expert Rev Vaccines (2013) 0.84
A substitution in the transmembrane region of the glycoprotein leads to an unstable attenuation of Machupo virus. J Virol (2014) 0.82
Activation of the RLR/MAVS Signaling Pathway by the L Protein of Mopeia Virus. J Virol (2016) 0.75
Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' End. Virology (1997) 1.44
Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus. J Virol (2001) 1.14
Newcastle disease virus-specific RNA: an analysis of 24 S and 35 S RNA transcripts. Acta Virol (1979) 1.03
Prediction of arenavirus fusion peptides on the basis of computer analysis of envelope protein sequences. FEBS Lett (1990) 1.01
Sequence comparison of the large genomic RNA segments of two strains of lymphocytic choriomeningitis virus differing in pathogenic potential for guinea pigs. Virus Genes (1998) 0.96
Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein. Vaccine (2000) 0.94
Ribonucleic acids of Machupo and Lassa viruses. Arch Virol (1984) 0.93
Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus. J Hum Virol (2001) 0.91
[The penetration of the Marburg virus into eukaryotic cells]. Vopr Virusol (1994) 0.90
Newcastle disease virus-specific RNA: hybridization-competition of the non-dissociable 35 S RNA with individual 18 S RNA species. Acta Virol (1979) 0.88
Early events in arenavirus replication are sensitive to lysosomotropic compounds. Arch Virol (1989) 0.87
Some biochemical properties of Lassa virus RNA and polypeptides. Med Microbiol Immunol (1986) 0.86
Lassa virus lethality for inbred mice. Ann Soc Belg Med Trop (1985) 0.83
[The localization and preliminary characteristics of antigenic sites (B epitopes) in the nucleocapsid protein of the Lassa virus]. Vopr Virusol (1994) 0.81
[Effect of actinomycin D on the reproduction of the Machupo virus]. Vopr Virusol (1985) 0.81
Reproduction of Lassa virus in different cell cultures. Acta Virol (1983) 0.81
Lassa virus glycoproteins: antigenic and immunogenic properties of synthetic peptides to GP1. Arch Virol (1990) 0.81
[False-positive reactions in laboratory diagnosis of Lassa, Marburg, and Ebola viral hemorrhagic fevers and AIDS]. Vopr Virusol (1997) 0.80
Newcastle disease virus-specific RNA: poly(A)-containing and poly(A)-deficient transcripts as revealed by chromatography on poly(U)-sepharose. J Virol (1976) 0.79
Sedimentation analysis of the RNAs isolated from interfering particles of Lassa and Machupo viruses. Acta Virol (1985) 0.78
[The cultivation and physicochemical properties of the Josiah strain of the Lassa virus]. Vopr Virusol (1991) 0.78
[Lysosomotropic agents inhibit the penetration of arenaviruses into a culture of BHK-21 and Vero cells]. Vopr Virusol (1990) 0.78
[Lassa and Mozambique viruses: cross protection in experiments on mice and action of immunosuppressants on experimental infections]. Vopr Virusol (1990) 0.77
[Serological evidence of Lassa virus circulation in the Republic of Guinea]. Vopr Virusol (1994) 0.77
L and S species of Machupo virion RNA contain a mixture of complementary strands. Brief report. Arch Virol (1986) 0.77
[The genotyping of strains of Borrelia burgdorferi sensu lato isolated in Byelarus from Ixodes ricinus ticks]. Med Parazitol (Mosk) (1999) 0.77
[Characteristics of monoclonal antibodies against Lassa virus]. Mol Gen Mikrobiol Virusol (1987) 0.77
[Pathogenicity of the Lassa virus for laboratory mice]. Vopr Virusol (1986) 0.76
[Factors affecting plaque formation by Lassa virus in Vero cells]. Vopr Virusol (1982) 0.76
[pH-dependent fusion of eukaryotic cells, caused by arenaviruses, pathogenic and non-pathogenic for humans]. Mol Gen Mikrobiol Virusol (1993) 0.75
[Effect of ribovirin (virazole) on arenavirus reproduction in cell cultures]. Vopr Virusol (1981) 0.75
[The detection of the Marburg virus antigen by solid-phase immunoenzyme analysis]. Vopr Virusol (1992) 0.75
[Experimental Lassa infection in monkeys and its treatment with ribamidil]. Vopr Virusol (1991) 0.75
[Pathogenic Machupo and Lassa arenaviruses: the biochemical properties of virion RNA and proteins]. Vopr Virusol (1987) 0.75
[Template activity of poly(A+) and poly(A-) messenger RNA of pathogenic arenaviruses]. Mol Gen Mikrobiol Virusol (1988) 0.75
[Virus-specific proteins and RNA of the virus of hemorrhagic fever with renal syndrome]. Vopr Virusol (1990) 0.75
[Sedimentation analysis of the virion RNA of Machupo virus]. Vopr Virusol (1983) 0.75
[Sedimentation properties of virion RNA of Newcastle disease virus after annealing under different conditions]. Vopr Virusol (1976) 0.75
[Fusion of artificial lipid membranes induced by synthetic "fusion peptide" of arenaviruses]. Biokhimiia (1991) 0.75
[A comparison of the methods of fluorescent antibodies and solid-phase immunoenzyme analysis in the detection of Marburg virus antibodies]. Vopr Virusol (1992) 0.75
[Accumulation of certain arenaviruses in transplantable VERO and BHK-21 cells]. Vopr Virusol (1981) 0.75
Machupo virus polypeptides: identification by immunoprecipitation. Arch Virol (1985) 0.75
[The isolation and characteristics of recombinant monoclonal antibodies to the Lassa virus]. Vopr Virusol (1991) 0.75
[Virus-specific poli(A)-containing RNA-transcripts in cells infected with Newcastle disease virus]. Vopr Virusol (1977) 0.75
[Specific clinical, epidemiological patterns and laboratory diagnostics of enterovirus infection in the Republic of Belarus]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.75
[Characteristics of 24S and 35S virus-specific RNA in cells infected with Newcastle disease virus]. Vopr Virusol (1977) 0.75
[Electron microscopic study of Lassa virus]. Vopr Virusol (1988) 0.75
[Acute and chronic Lassa virus infection of Vero cells]. Vopr Virusol (1982) 0.75
[Method for the simultaneous detection of immunofluorescing antibodies to the causative agents of different hemorrhagic fevers]. Vopr Virusol (1986) 0.75
[Molecular mechanisms of the reproduction of phlebo- and arenaviruses]. Vopr Virusol (1989) 0.75
[The detection of a presumed fusion peptide comprising the surface glycoproteins of arenaviruses]. Vopr Virusol (1991) 0.75
[Isolation and characteristics of low molecular weight recombinant peptides, representing antigenic domains in the NP protein of lymphocytic choriomeningitis virus]. Vopr Virusol (2000) 0.75
[Sedimentation characteristics of virion RNA of Machupo virus reproducing in the presence of actinomycin D]. Mol Gen Mikrobiol Virusol (1985) 0.75
[Characteristics of the subvirion components formed after the treatment of Machupo virus with a nonionic detergent]. Vopr Virusol (1985) 0.75
[Identification of the mRNA of the nucleocapsid proteins of pathogenic arenaviruses]. Vopr Virusol (1988) 0.75
[Recombinant monoclonal antibodies to the Lassa virus: the formation of reactive paratopes]. Vopr Virusol (1991) 0.75
[Molecular biological monitoring of the polioviruses circulation in Belarus]. Zh Mikrobiol Epidemiol Immunobiol (2003) 0.75
[Detection and antigenic characteristics of the recombinant nucleocapsid proteins of Lassa and Marburg viruses]. Vopr Virusol (2012) 0.75
Cloning of variable fragments of tumor immunoglobulin, assembling and expressing of human SCFV protein in E. coli for anti-idiotype vaccination. Exp Oncol (2013) 0.75
[Detection of virus-specific RNA in cell systems persistently infected with the influenza virus]. Mikrobiol Zh (1982) 0.75
In vitro translation of mRNA species from cells infected with Machupo virus. Arch Virol (1987) 0.75
[Utilization of poly U-cellulose and poly U-sepharose for the study of virus-specific RNA of Newcastle disease virus]. Vopr Virusol (1977) 0.75
[Mutation and recombination variability of vaccine polioviruses isolated in Belarus (1960-1999)]. Mol Gen Mikrobiol Virusol (2002) 0.75
Phenotypic mixing of vesicular stomatitis virus (VSV) with vaccinia virus. Acta Virol (1982) 0.75